Register entry
- Registered sites
- 0
- Active NDC listings
- 3
- Live patents
- 1
- Exclusivities
- 1
- Countries
- 0
Catalogue
Drug listings by form and route
33 active NDC listings: 3 human prescription drug. By marketing category: NDA 2, ANDA 1.
| Dosage form | NDCs |
|---|---|
| injection, powder, lyophilized, for solution | 1 |
| tablet | 1 |
| tablet, film coated | 1 |
| Route | NDCs |
|---|---|
| oral | 2 |
| intravenous | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| uswm, llc | 3 |
Exclusivity
Patents and exclusivities
1| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 12582625 | IWILFINeflornithine hydrochloride | use | Feb 2036 |
| Product | Exclusivity | Until |
|---|---|---|
| IWILFINEFLORNITHINE HYDROCHLORIDE | ODE-462 Orphan drug | Dec 2030 |
Catalogue
Marketed products
3| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Lucemyra | lofexidine hydrochloride | tablet, film coated, oral | 78670-050NDA |
| Revonto | dantrolene sodium | injection, powder, lyophilized, for solution, intravenous | 78670-003ANDA |
| iwilfin | EFLORNITHINE HYDROCHLORIDE | tablet, oral | 78670-150NDA |
Compare
Other companies listing eflornithine hydrochloride
- CORERX, INC.1 site · 12 NDC
Enquiry
Common questions
- Is USWM, LLC FDA approved?
- USWM, LLC holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does USWM, LLC make?
- 3 products are listed under USWM, LLC in the openFDA NDC Directory, most often as injection, powder, lyophilized, for solution; tablet; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.